Novavax (NASDAQ:NVAX) has had a phenomenal year in 2020. The mid-cap opened in January as a micro-cap, starting off the year at $4 a share. Nine months later, its shares are trading hands for $113. T… [+5663 chars]
Will Big Pharma Acquire Novavax? – Motley Fool
